Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
10.84
-0.04 (-0.37%)
Dec 20, 2024, 4:00 PM EST - Market closed

Third Harmonic Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-39.2-30.82-35.16-29.61-12.81
Depreciation & Amortization
0.050.040--
Stock-Based Compensation
9.659.584.750.510.2
Other Operating Activities
0.710.560.0410.611.69
Change in Accounts Payable
0.91-0.250.291.220.32
Change in Other Net Operating Assets
-10.47-4.841.531.41
Operating Cash Flow
-28.88-20.43-34.92-15.75-9.19
Capital Expenditures
-0-0.17-0.04--
Investing Cash Flow
-0-0.17-0.04--
Issuance of Common Stock
51.51.26198.29--
Other Financing Activities
-0.41-0.47-2.29--
Financing Cash Flow
51.090.8195.99135.7510.83
Net Cash Flow
22.21-19.8161.041201.64
Free Cash Flow
-28.88-20.59-34.95-15.75-9.19
Free Cash Flow Per Share
-0.71-0.52-2.44-3.89-2.50
Levered Free Cash Flow
-23.56-18.04-22.34-8.62-
Unlevered Free Cash Flow
-23.56-18.04-22.34-8.62-
Change in Net Working Capital
0.240.013.49-2.74-
Source: S&P Capital IQ. Standard template. Financial Sources.